I wonder, when we're looking at the review that's been done and the Government's response to it, when you're looking at the broader picture of how we do equity, whether there is any proposal that you will look at those things and think, "Well, if somebody with cystic fibrosis, for example, has access to this medication, which means they're not going to hospital every few months for usually one to two weeks at a time"—which has been estimated, through that petition, at $40,000 a time; $60,000 estimated for a lung transplant—a massive, massive pressure on the health system for that. So I think, in that bigger picture, the potential to offset rather than just the contained amount of "This is Pharmac funding, this little box here" to say, "Right, we're going to save substantial money over here. How can we do something that just acknowledges the impact it will have in the longer term?" So, yeah, I'm interested to hear about that.